Gloria Alzuet

Toward the development of metal-based synthetic nucleases: DNA binding and oxidative DNA cleavage of a mixed copper(II) complex with N-(9H-purin-6-yl)benzenesulfonamide and 1,10-phenantroline. Antitumor activity in human Caco-2 cells and Jurkat T lymphocytes. Evaluation of p53 and Bcl-2 proteins in the apoptotic mechanism.

The complex [Cu(N9-ABS)(phen)2].3.6H2O, H2N9-ABS = N-(9H-purin-6-yl)benzenesulfonamide and phen = 1,10-phenanthroline, has been synthesized and then characterized with the aid of X-ray diffraction, analytical, and spectroscopic techniques. The geometry of Cu(II) is distorted square pyramidal with the equatorial positions occupied by three N atoms from two phenantroline molecules and one N atom from the adenine ring of the sulfonamide ligand. The interaction of the complex with DNA was studied by means of viscosity measurements and fluorescence spectroscopy. The results pointed to a classic intercalation of the complex between the DNA base pairs. The complex was found to be a very efficient agent of plasmid DNA cleavage in the presence of ascorbate. Both the kinetics and the mechanism of the cleavage reaction were studied. In addition, the cytotoxic properties of the complex were evaluated in human Jurkat T and Caco-2 cell lines. The cytotoxicity of the compound was higher than that of the reference ([Cu(phen)2]2+). The mechanism and type of cell death induced by the compound was determined by flow cytometry and Hoechst dye staining. The compound demonstrated a significant ability to induce cell death by apoptosis. The apoptosis induced by [Cu(N9-ABS)(phen)2].3.6H2O was associated with an increase in p53 protein levels while those of Bcl-2 were reduced.

Coordination behaviour of sulfanilamide derivatives.: Crystal structures of [Hg(sulfamethoxypyridazinato)2], [Cd(sulfadimidinato)2(H2O)]·2H2O and [Zn(sulfamethoxazolato)2-(pyridine)2(H2O)2]

Abstract Hg(II), Cd(II) and Zn(II) complexes with the ligands sulfadimethoxine, sulfamethoxypyridazine, sulfadiazine, sulfamerazine, sulfadimidine and sulfamethoxazole have been prepared and characterised by spectral data. 1H and 13C NMR have been used to interpret the structural characteristics of the complexes in solution. The X-ray crystal structures of [Hg(sulfamethoxypyridazinato)2] (2a), [Cd(sulfadimidinato)2(H2O)]·2H2O (4b) and [Zn(sulfamethoxazolato)2(py)2(H2O)2] (6d) have been determined. In complex 2a the Hg(II) ion lies on an inversion centre and exhibits linear coordination by two sulfonamidic nitrogen atoms [Hg–N(1)=2.071(4) A] of the two deprotonated sulfamethoxypyridazinato ligands. The polymeric Cd(II) complex (4b) exhibits a high distorted-octahedral geometry, involving the sulfonamidic nitrogen [Cd–N(1)=2.328(6); Cd–N(1′)=2.326(6) A] and the heterocyclic N(3)/N(2′) [Cd–N(3)=2.307(6) A; Cd–N(2′)=2.426(6) A] of two bidentate sulfadimidine ligands, the terminal amino N(4′b) [Cd–N(4′b)=2.379(7) A] of a third sulfadimidine which is bonded to an adjacent Cd(II), and the O(3) atom of a coordinated water molecule [Cd–O(3)=2.334(6) A]. In complex 6d the geometry around the Zn(II) ion can be described as a slightly distorted compressed octahedron. Two pyridine [Zn–N(16)=2.1841(17) A] and two isoxazole N atoms [Zn–N(2)=2.1736(15) A] are located in the equatorial plane and two oxygen atoms of two water molecules [Zn–O(4)=2.0984(14) A] are placed in the apical positions. IR and NMR spectral studies suggest a similar behaviour of the Cd(II) and Zn(II) complexes, both in solid state and solution, and different to the corresponding Hg(II) complexes. Thus 1H and 13C NMR spectra, in DMSO-d6, of Cd(II) and Zn(II) compounds show coordination mainly through the heterocyclic nitrogen while the corresponding Hg(II) derivatives seem to be coordinated through the sulfonamidic nitrogen.

COORDINATION BEHAVIOR OF SULFATHIAZOLE. CRYSTAL STRUCTURE OF CU(SULFATHIAZOLE) (PY)3CL SUPEROXIDE DISMUTASE ACTIVITY

Abstract The preparation, spectroscopic, magnetic properties, and crystal structure of [Cu(stzxpy) 3 Cl] (stz − stands for the deprotonated form of sulfathiazole, 4-amino-N-2-thiazolylbencenosulfonamide) are reported. Crystals are orthorhombic, space group Pbca, with cell constants a = 15.834(2), b = 17.512(4), and c = 18.79(2) A, and Z = 8. The structure was solved and refined to R = 0.041 (R W = 0.040). The structure consists of mononuclear units linked via hydrogen bonds to form the tridimensional pyramid. The geometry of CuN3N*NCl chromophore is distorted square-pyramid. The superoxide-dismutase mimetic activity of the compound is measured and compared with those of the SOD enzyme, the free drug, and other related sulfathiazole complexes.

Superoxide dismutase activity of ternary copper complexes of sulfathiazole and imidazole derivatives. Synthesis and properties of [CuL2(R-Him)2] [HL=4-amino-N-(thiazol-2-yl)benzenesulfonamide, R-Him=4-methylimidazole, 4,4-dimethylimidazoline or 1,2-dimethylimidazole]. Crystal structure of [CuL2(4,4-dimethylimidazoline)2]

Abstract New ternary copper(II) complexes of sulfathiazole (4-amino-N-(thiazol-2-yl)benzenesulfonamide)(HL) and methyl imidazole derivatives have been synthesised and characterised. The crystal structure of the complex [CuL2(4,4-dmHim)2] (1) [4,4-dmHim=4,4-dimethylimidazoline] has been determined. The copper centre has a quasi regular square planar environment with Cu-nitrogen bond lengths ranging from 1.952 to 2.010 A. From the spectroscopic properties of the complexes [CuL2(1,2-dmHim)2] (2) [1,2-dmHim=1,2-dimethylimidazole] and [CuL2(4-mHim)2] (3) [4-mHim=4-methylimidazole] a distorted tetragonal octahedral geometry is deduced. The compounds showed SOD mimetic activity in fact, a low concentration of the complexes catalyses the dismutation of superoxide at biological pH. This SOD activity is correlated with their structural properties. Using Extended Huckel Molecular Orbital Calculations the one-electron energy levels of the CuN4 chromophore in complex 1 are reported and correlated with the data of the CuN6 and CuN5 chromophores of the previously reported [CuL2(Him)2]·MeOH and [CuL2(mim)2]·H2O compounds. In addition, the influence of the geometry distortion on the composition and energy of the molecular orbitals is described using idealised models.

Oxidative nuclease activity of ferromagnetically coupled μ-hydroxo-μ-propionato copper(II) complexes [Cu3(L)2(μ-OH)2(μ-propionato)2] (L = N-(pyrid-2-ylmethyl)R-sulfonamidato, R = benzene, toluene, naphthalene)

Three doubly-bridged, trinuclear copper(II) compounds with hydroxo and carboxylato bridges, (infinity)(1)[Cu(3)(L1)(2)(mu-OH)(2)(mu-propionato)(2)](1), [Cu(3)(L2)(2)(mu-OH)(2)(mu-propionato)(2)(DMF)(2)] (2) and (infinity)(1){[Cu(3)(L3)(2)(mu-OH)(2)(mu-propionato)(2)]} [Cu(3)(L3)(2)(mu-OH)(2)(mu-propionato)(2)(DMF)(2)]} (3) [HL1=N-(pyrid-2-ylmethyl)benzenesulfonylamide, HL2=N-(pyrid-2-ylmethyl)toluenesulfonylamide, HL3=N-(pyrid-2-ylmethyl)naphthalenesulfonylamide], have been synthesized and characterized. 1 is built from [Cu(3)(L1)(2)(mu-OH)(2)(mu-propionato)(2)] clusters. Each unit contains three copper(II) with two different coordination environments: the terminal centers are square-base pyramidal whereas the central copper is square planar. 2 presents a similar square-base pyramidal geometry in the terminal centers, but the central copper is six-coordinate. 3 shows an unusual 1D coordination polymer comprised of two distinct building blocks: one similar to that found in 1 and the other similar to that found in 2. The magnetic susceptibility measurements (2-300K) reveal a ferromagnetic interaction between the Cu(II) ions with J values of 76.0, 55.0, and 48.0cm(-1) for 1, 2, and 3, respectively. Emission spectroscopy, thermal denaturation, viscosimetry and cyclic voltammetry show an interaction of the complexes with DNA through the sugar-phosphate backbone. All three Cu(II) complexes were found to be very efficient agents of plasmid DNA cleavage in the presence of ascorbato or mercaptopropionic acid. Both the kinetics and the mechanism of the cleavage reaction have also been examined.

Metal complexes of sulfanilamide derivatives. Crystal structure of [Zn(sulfathiazole)2]·H2O

Abstract The crystal structure of the Zn(sulfathiazole) 2 ·H 2 O complex is reported. The complex crystallizes in the monoclinic space group C 2/ c . The cell dimensions are a = 9.098(3) A, b = 17.871(5) A, c = 14.61(1) A, β = 99.44(6)°, V = 2343(2) A 3 , Z = 4, and D x = 1.68 g/cm 3 . The final conventional R-factor = 0.027 for 2669 “observed” reflections and 191 variables. The Zn ion is surrounded in a regular tetrahedral arrangement by two N amino and two N thiazole atoms pertaining to four sulfathiazole (Hstz) ligands. Each stz anion, acting as a bidentate ligand, chelates to two Zn ions as a bridge through the N thiazole and the N amino atoms. The IR, 13 C NMR in solid state, 1 H NMR, and 13 C NMR in DMSO d6 solutions spectra are discussed in detail with regard to the crystal structure.

Coordination behavior of sulfathiazole. Crystal structure of dichloro-disulfathiazole ethanol Cu(II) complex. Superoxide dismutase activity

Abstract The crystal structure of [Cu(sulfathiazole) 2 (EtOH)Cl 2 ) (triclinic; a = 7.82(1), b = 11.441(3), c = 16.606(6) A, α = 109.68(4), β= 102.24(4), γ 91.27(4)°, Z = 2, space group P 1 ) has been determined from the intensities of 2605 independent reflections (graphite monochromator MoKα; 4-circle diffractometer; R = 4.5%). The coordination polyhedron around Cu(II) ion is intermediate between square pyramid are trigonal bipyramid. The spectroscopic data and the rhombic powder EPR spectrum are in agreement with the distorted geometry of the Cu(II) ion. The superoxide dismutase activity of the title compound has been measured and compared with those of the free drug and other sulfathiazole complexes.

Crystal structures and superoxide dismutase mimetic activity of [CuL2(Him)2]·MeOH and [CuL2(mim)2]·H2O [HL = 4-amino-N-(thiazol-2-yl)benzenesulfonamide, Him = imidazole, mim =N-methylimidazole]

The complexes [CuL2(Him)2]·MeOH 1 and [CuL2(mim)2]·H2O 2[HL = 4-amino-N-(thiazol-2-yl)-benzenesulfonamide, Him = imidazole, mim =N-methylimidazole] have been prepared and their crystal structures determined. In 1 the metal centre has a very irregular stereochemistry, being co-ordinated by six nitrogen atoms, two of them from the imidazole ligands and the other four from three sulfonamides, one belonging to an adjacent asymmetric unit. The crystal packing shows stacking interactions between the imidazole and phenyl rings of the sulfonamide. In 2 the co-ordination polyhedron is intermediate between square pyramidal and trigonal bipyramidal. Spectroscopic and electrochemical data are in accord with the crystal structures. The in vitro O2– scavenger activity of the complexes shows that they exhibit high superoxide-dismutase mimetic activity.

Crystal structure, magnetic and spectroscopic properties of copper(II) formato dimethylformamide: a new tetracarboxylato-bridged copper(II) dimer

Abstract The crystal and molecular structure of a new tetracarboxylato copper(II) dimer [bis(dimethylformamide)tetrakis(μ-formato)dicopper(II)], has been determined by X-ray diffraction methods. The crystal structure consists of a centrosymmetric dimer [Cu2(HCOO)4(dmf)2], where four bidentate formato anions form syn–syn bridges between the metal ions which are in a 4+1 environment. Magnetic susceptibility data show that the copper ions are strongly antiferromagnetically coupled with J=−470 cm−1. The EPR spectrum shows a characteristic pattern of a triplet state with a D zero field splitting value of 0.27 cm−1.

Structural and functional models for the dinuclear copper active site in catechol oxidases: Synthesis, X-ray crystal structures, magnetic and spectroscopic properties of μ-methoxo-bridged dinuclear copper(II) complexes with N-substituted sulfonamide ligands

Two new mu-methoxo-bridged dinuclear copper(II) complexes with a N-substituted sulfonamide, [Cu(mu-OMe)(L)(NH(3))](2) (1) and [Cu(mu-OMe)(L)(DMSO)](2) (2) [HL, N-2-(4-methylbenzothiazole)benzenesulfonamide], have been prepared and characterized by single-crystal X-ray difraction analyses. Compound 1 crystallizes in the monoclinic space group C(2)/c with a=22.0678(18), b=7.9134(7), c=21.1186(18)A, beta=113.788(4) degrees and Z=8. Compound 2 crystallizes in the monoclinic space group C(2)/c with a=18.0900(10), b=9.5720(10), c=24.2620(10) A, beta=98.7120(10) degrees and Z=8. In both complexes the copper atoms have square-planar environments bridged by two oxygen atoms from methoxide groups. Magnetic susceptibility measurements indicate a very strong antiferromagnetic coupling between the copper(II) ions in both complexes (2J<-1000 cm(-1)). Electronic Paramagnetic Resonance (EPR) spectra of the two complexes both in solid and in solution are silent. 13C NMR spectra of the complexes in solid state have been studied. The complexes have been evaluated as model systems for the catechol oxidase enzyme using 3,5-di-tert-butylcatechol as the test substrate. Complex 2 is slightly more active than complex 1.